Regulus Therapeutics | RGLS - Koszty Sprzedaży I Administracji



Koszty Sprzedaży I Administracji Zmiana Data
Alnylam Pharmaceuticals USD 282.51M 2.55M 2026-03
Alterity Therapeutics Limited AUD 1.45M 703.96K 2025-12
AstraZeneca USD 5.06B 455M 2026-03
Biogen USD 554.3M 128.2M 2026-03
Celldex Therapeutics USD 11.45M 3.61M 2026-03
Cipla INR 13.25B 101.8M 2025-12
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.43M 222K 2026-03
CSL USD 1.23B 498M 2025-12
Gilead Sciences USD 1.45B 326M 2026-03
GlaxoSmithKline GBP 2.12B 558M 2026-03
Grifols EUR 320.45M 12.65M 2025-12
Immunic USD 3.45M 451K 2025-12
Incyte USD 328.1M 62.31M 2026-03
Intrexon USD 10.31M 41K 2024-06
Ionis Pharmaceuticals USD 151M 21M 2026-03
Lexicon Pharmaceuticals USD 3.98M 195K 2025-12
Ligand Pharmaceuticals USD 20.84M 4.19M 2026-03
Merck USD 2.67B 180M 2026-03
Omeros USD 11.32M 2.48M 2024-09
Sangamo BioSciences USD 9.64M 1.83M 2024-06
Sanofi EUR 2.49B 252M 2026-03
Takeda JPY 292B 9.21B 2026-03